Biotech

All Articles

Analysts explore Avidity's DMD succeed, uncovering nuances in records

.Avidity Biosciences amazed entrepreneurs along with phase 1/2 information in Duchenne muscular dyst...

Actinogen's cortisol blocker stops working stage 2 depression research study

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a phase 2 research s...

Bivictrix chooses going personal only means to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually been at the facility of many a billion-dollar biobuck...

TPG tops up funds to $580M for assets across lifestyle sciences

.Possession supervisor TPG, which has actually sustained biotechs like Sionna Therapeutics and Santa...

Merck stops period 3 TIGIT test in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT system has gone through one more problem. Months after shuttering a phase 3 ...

After a difficult year, Exscientia folds right into Recursion

.After a year described by pipeline hairstyles, the departure of its chief executive officer as well...

Cullinan, after $25M bargain, return bispecific to Harbour

.Cullinan Therapeutics was actually made an impression on good enough along with Port BioMed's bispe...

A deeper take a look at Brutal Biotech's Fierce 15

.In this full week's episode of "The Best Line," we're diving in to Fierce Biotech's yearly Strong 1...

Lilly encounters stage 2 breakdown of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's celebration celebrating the commendation of...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...